Brandi ML - Search Results

1

Isolation and characterization of a new cell line from a renal carcinoma bone metastasis.

Avnet S, Cenni E, Granchi D, Perut F, Amato I, Battistelli L, Brandi ML, Giunti A, Baldini N. Avnet S, et al. Among authors: brandi ml. Anticancer Res. 2004 May-Jun;24(3a):1705-11. Anticancer Res. 2004. PMID: 15274344 Free article.

2

In vitro blockade of receptor activator of nuclear factor-kappaB ligand prevents osteoclastogenesis induced by neuroblastoma cells.

Granchi D, Amato I, Battistelli L, Avnet S, Capaccioli S, Papucci L, Donnini M, Pellacani A, Brandi ML, Giunti A, Baldini N. Granchi D, et al. Among authors: brandi ml. Int J Cancer. 2004 Oct 10;111(6):829-38. doi: 10.1002/ijc.20308. Int J Cancer. 2004. PMID: 15300794

3

Inhibition of angiogenic activity of renal carcinoma by an antisense oligonucleotide targeting fibroblast growth factor-2.

Cenni E, Perut F, Zuntini M, Granchi D, Amato I, Avnet S, Brandi ML, Giunti A, Baldini N. Cenni E, et al. Among authors: brandi ml. Anticancer Res. 2005 Mar-Apr;25(2A):1109-13. Anticancer Res. 2005. PMID: 15868953 Free article.

4

Primitive and bone metastatic renal carcinoma cells promote osteoclastogenesis through endothelial cells.

Cenni E, Perut F, Granchi D, Amato I, Avnet S, Brandi ML, Giunti A, Baldini N. Cenni E, et al. Among authors: brandi ml. Anticancer Res. 2006 Jul-Aug;26(4B):3065-9. Anticancer Res. 2006. PMID: 16886635 Free article.

5

Interferon-alpha inhibits in vitro osteoclast differentiation and renal cell carcinoma-induced angiogenesis.

Avnet S, Cenni E, Perut F, Granchi D, Brandi ML, Giunti A, Baldini N. Avnet S, et al. Among authors: brandi ml. Int J Oncol. 2007 Feb;30(2):469-76. Int J Oncol. 2007. PMID: 17203230

6

Inhibition of angiogenesis via FGF-2 blockage in primitive and bone metastatic renal cell carcinoma.

Cenni E, Perut F, Granchi D, Avnet S, Amato I, Brandi ML, Giunti A, Baldini N. Cenni E, et al. Among authors: brandi ml. Anticancer Res. 2007 Jan-Feb;27(1A):315-9. Anticancer Res. 2007. PMID: 17352248 Free article.

7

Growth response of colon cancer cell lines to selective estrogen receptor modulators.

Picariello L, Fiorelli G, Martineti V, Tognarini I, Pampaloni B, Tonelli F, Brandi ML. Picariello L, et al. Among authors: brandi ml. Anticancer Res. 2003 May-Jun;23(3B):2419-24. Anticancer Res. 2003. PMID: 12894523

8

Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury?

Masi L, Simonini G, Piscitelli E, Del Monte F, Giani T, Cimaz R, Vierucci S, Brandi ML, Falcini F. Masi L, et al. Among authors: brandi ml. J Rheumatol. 2004 May;31(5):986-91. J Rheumatol. 2004. PMID: 15124262

9

ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components.

Martineti V, Picariello L, Tognarini I, Carbonell Sala S, Gozzini A, Azzari C, Mavilia C, Tanini A, Falchetti A, Fiorelli G, Tonelli F, Brandi ML. Martineti V, et al. Among authors: brandi ml. Endocr Relat Cancer. 2005 Jun;12(2):455-69. doi: 10.1677/erc.1.00861. Endocr Relat Cancer. 2005. PMID: 15947116

10

Production of interleukin-6 by human osteoclast-like cells from giant cell tumor of bone.

Giovannini M, Strippoli P, Serra M, Sironi M, Fincato G, Colotta F, Bonafe M, Biunno I, Mantovani A, Orlandini S, Brandi M, Pastano R, Bagnara G. Giovannini M, et al. Int J Oncol. 1996 Feb;8(2):297-303. doi: 10.3892/ijo.8.2.297. Int J Oncol. 1996. PMID: 21544359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

925 results

Search Page

Filters